Scientists hunt for hidden proteins on hepatitis b virus
NCT ID NCT02798549
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looked at human proteins that stick to hepatitis B virus particles in blood samples from 14 infected adults. The goal was to identify these proteins and understand how they help the virus survive and spread. This is basic research, not a treatment, but it may point toward new ways to fight the virus in the future.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could reveal new targets for future hepatitis B treatments.
- What could go wrong
- This is a very small, early-stage study (14 participants) focused on basic biology, not a treatment trial. The findings may not lead to any practical therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS B VIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service d'Hépato-Gastroentérologie, Hopital de la Croix-Rousse, Hospices Civils de Lyon
Lyon, Auvergne-Rhône-Alpes, 69004, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New blood test may sharpen diagnosis of autoimmune liver disease
- New hope for kids with hepatitis b: drug combo aims for cure
- Could a drug combo cure hepatitis b in kids? new trial aims to find out
- Mass hepatitis b screening aims to prevent liver cancer in thailand
- Scientists dive into immune 'Training Centers' to unlock hepatitis b secrets
- Herbal blend shows promise against COVID-19 in small trial